Skip to main content

Currently Skimming:

Forum Themes and Priorities
Pages 12-17

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 12...
... There is also increasing recognition of the need for new models and methods for drug development and translational science, and "precompetitive collaborations" and other partnerships, including public–private partnerships, are proliferating. The Forum offers a venue to discuss effective collaboration in the drug discovery and development enterprise and also hosts discussions that could help chart a course through the turbulent forces of disruptive innovation in the drug discovery and development "ecosystem." February 26 March 3–4 Workshop: Building a National South Africa Workshop: The Framework for the Establishment Emerging Threat of Multidrug of Regulatory Science for Resistant Tuberculosis April 29–30 Drug Development Forum Meeting #15 2010 February 22-24 May 26–27 Workshop: The Public Health Emergency Medical Countermeasures Russia Workshop: The New Profile Enterprise (in collaboration with the Medical Preparedness Forum)
From page 13...
... Recent rapid advances in innovative research devel • Biomedical drug Innovation & the Enterprise • Academia • Federal research & foundations opment science present opportunity for revolutionary developments of new scientific Partners Priorities Science Across the Lifecycle regulatory agencies • Disease advocacy • Large pharmaceutical organizations techniques, therapeutic products, and applications. The Forum provides a venue to focus Clinical Trials & Product Development companies • Patients, consumers, & • Small biotechnology & research participants ongoing attention and visibility to these important drugcompanies emerging development needs and facilitates Infrastructure & Workforce exploration of new approaches across the drug development lifecycle.
From page 14...
... In addition to sponsoring multiple symposia and workshops, under this initiative, the July 12 South Africa Workshop Summary November 7–8 Report Release: The Emerging Threat of Workshop: Envisioning a Transformed Multidrug-Resistant Tuberculosis: Global Clinical Trials Enterprise in the United June 28–29 October 4–5 States: Establishing an Agenda for 2020 and Local Challenges and Solutions Forum Meeting #19 Forum Meeting #20 2012 June 27–28 September 20–21 Workshop: Public Engagement and Clinical Workshop: Strengthening a Workforce for Innovative Trials: New Models and Disruptive Technologies Regulatory Science in Therapeutics Development
From page 15...
... It has convened workshops examining these issues, includ ing consideration of strategies for developing a discipline of innovative regulatory science through the development of a robust workforce. October 4–5 June 4–5 Workshop: Sharing Clinical Workshop: Maximizing the Goals of Research Data (in collaboration the Cures Acceleration Network to with the Neuroscience Forum, March 13–14 Accelerate the Development of New June 5 National Cancer Policy Forum, Forum Meeting #21 Drugs and Diagnostics Forum Meeting #22 and Genomics Roundtable)
From page 16...
... Strategies • Facilitating attention, visibility, and continuous discussion • Workshop summaries • Defining the scope of the field Products • Workshops in brief • Educating and elevating understanding of issues • Discussion papers & • Clarifying and expanding areas of agreement commentaries • Exploring new approaches to gridlocked areas • Fostering collaboration * Spinoff consensus studies • Setting the stage for policy action November 26–27 January 15 Workshop: Large Simple Trials and Workshop Summary Report January 16–18 February 13–14 Knowledge Generation in a Learning Release: Developing and China Workshop: The Global Workshop: International Regulatory Health System (in collaboration with Strengthening the Global Supply Crisis of Drug-Resistant Harmonization Amid Globalization the Roundtable on Value & Science- Chain for Second-Line Drugs for Tuberculosis and Leadership of Biomedical Research & Medical Driven Health Care)
From page 17...
... March 11 February 12 Action Collaborative Workshop: Characterizing and Meeting #3: Developing August 21 Communicating Uncertainty in the a National Accreditation Action Collaborative Meeting #2: Assessment of Benefits and Risks of System to Improve Clinical Developing a National Accreditation System Pharmaceutical Products (Day 1) Trial Performance to Improve Clinical Trial Performance 2014 October 28–29 March 3–4 Forum Meeting #26 Forum Meeting #27


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.